MeCP2 affects skeletal muscle growth and morphology through non cell-autonomous mechanisms

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Conti, Valentina ^a   Gandaglia, Anna ^a,b   Galli, Francesco ^a   Tirone, Mario ^a,c   Bellini, Elisa ^a   Campana, Lara ^a,d   Kilstrup Nielsen, Charlotte ^b   Rovere Querini, Patrizia ^a,d   Brunelli, Silvia ^c   Landsberger, Nicoletta ^a,e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MAMMALIAN TARGET OF RAPAMYCIN; METHYL CPG BINDING PROTEIN 2; PROTEIN KINASE B; SOMATOMEDIN C; BRAIN DERIVED NEUROTROPHIC FACTOR; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; MECP2 PROTEIN, MOUSE; MTOR PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; MALE; MECP2 GENE; MOUSE; MUSCLE ATROPHY; MUSCLE DISEASE; MUSCLE GROWTH; MUSCLE HYPOTONIA; MUSCLE METABOLISM; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; RETT SYNDROME; ANIMAL; C57BL MOUSE; DISEASE MODEL; FIBROSIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

MUS;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE HYPOTONIA; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-AKT; RETT SYNDROME; TOR SERINE-THREONINE KINASES;

EID: 84939137447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130183     Document Type: Article

References (41)

1. Percy AK, Lane JB (2005) Rett Syndrome: Model of Neurodevelopmental Disorders. Journal of Child Neurology 20: 718-721.
2. Kilstrup-Nielesen C, Landsberger N (2014) Rett syndrome from the involved gene(s) to treatment. In: Zigmond M, Rowland LP, Coyle JT, editors. Neurobiology of brain disorders Elsevier.
3. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al. (2010) Rett syndrome: Revised diagnostic criteria and nomenclature. Annals of Neurology 68: 944-950. doi: 10.1002/ana.22124
4. Chahrour M, Zoghbi HY (2007) The Story of Rett Syndrome: From Clinic to Neurobiology. Neuron 56: 422-437.
5. Ricceri L, De Filippis B, Laviola G (2008) Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol 19: 501-517. doi: 10.1097/FBP.0b013e32830c3645
6. Skene PJ, Illingworth RS, Webb S, Kerr ARW, James KD, Turner DJ, et al. (2010) Neuronal MeCP2 Is Expressed at Near Histone-Octamer Levels and Globally Alters the Chromatin State. Molecular Cell 37: 457-468. doi: 10.1016/j.molcel.2010.01.030
7. Ballas N, Lioy DT, Grunseich C, Mandel G (2009) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nature neuroscience 12: 311-317. doi: 10.1038/nn.2275
8. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SBG, Guyenet PG, et al. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 483: 105-109.
9. Alvarez-Saavedra M, Carrasco L, Sura-Trueba S, Demarchi Aiello V, Walz K, Neto JX, et al. (2010) Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. Human molecular genetics 19: 2177-2190. doi: 10.1093/hmg/ddq096
10. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature genetics 27: 322-326.
11. Eyre JA, Kerr AM, Miller S, O'Sullivan MC, Ramesh V (1990) Neurophysiological observations on corticospinal projections to the upper limb in subjects with Rett syndrome. Journal of Neurology, Neurosurgery and Psychiatry 53: 874-879.
12. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, et al. (2009) Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Sciences 106: 2029-2034. doi: 10.1073/pnas.0812394106
13. Corvin AP, Molinos I, Little G, Donohoe G, Gill M, Morris DW, et al. (2012) Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. Neurosci Lett 520: 51-56. doi: 10.1016/j.neulet.2012.05. 029
14. Mellios N, Woodson J, Garcia RI, Crawford B, Sharma J, Sheridan SD, et al. (2014) b2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences 111: 9947-9952. doi: 10. 1073/pnas.1309426111
15. Castro J, Garcia RI, Kwok S, Banerjee A, Petravicz J, Woodson J, et al. (2014) Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proceedings of the National Academy of Sciences 111: 9941-9946. doi: 10.1073/pnas.1311685111
16. Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, Stefanelli G, et al. (2011) Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Human Molecular Genetics 20: 1182-1196. doi: 10.1093/hmg/ddq563
17. Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, et al. (2013) Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13: 446-458. doi: 10.1016/j.stem.2013.09.001
18. Pitts EV, Potluri S, Hess DM, Balice-Gordon RJ (2006) Neurotrophin and Trk-mediated signaling in the neuromuscular system. Int Anesthesiol Clin 44: 21-76.
19. Chevrel G, Hohlfeld R, Sendtner M (2006) The role of neurotrophins in muscle under physiological and pathological conditions. Muscle Nerve 33: 462-76.
20. Clow C, Jasmin BJ (2010) Brain-derived neurotrophic factor regulates satellite cell differentiation and skeltal muscle regeneration. Mol Biol Cell 21: 2182-90. doi: 10.1091/mbc.E10-02-0154
21. Katz DM (2014) Brain-derived neurotrophic factor and Rett syndrome. Handb Exp Pharmacol 220: 481-495. doi: 10.1007/978-3-642-45106-5-18
22. Fyffe SL, Neul JL, Samaco RC, Chao H-T, Ben-Shachar S, Moretti P, et al. (2008) Deletion of Mecp2 in Sim1-Expressing Neurons Reveals a Critical Role for MeCP2 in Feeding Behavior, Aggression, and the Response to Stress. Neuron 59: 947-958. doi: 10.1016/j.neuron.2008.07.030
23. Chen JCJ, Mortimer J, Marley J, Goldhamer DJ (2005) MyoD-cre transgenic mice: a model for conditional mutagenesis and lineage tracing of skeletal muscle. Genesis (New York, NY: 2000) 41: 116-121.
24. Kerr B, Alvarez-Saavedra M, Saez MA, Saona A, Young JI (2008) Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice. Hum Mol Genet 17: 1707-1717. doi: 10.1093/hmg/ddn061
25. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M (2013) Mechanisms regulating skeletal muscle growth and atrophy. The FEBS journal 280: 4294-4314. doi: 10.1111/febs.12253
26. Chikani V, Ho KKY (2013) Action of GH on skeletal muscle function: molecular and metabolic mechanisms. Journal of molecular endocrinology 52: R107-R123. doi: 10.1530/JME-13-0208
27. Khwaja OS, Ho E, Barnes KV, O'Leary HM, Pereira LM, Finkelstein Y, et al. (2014) Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci U S A 111: 4596-4601. doi: 0.1073/pnas.1311141111
28. Schiaffino S, Mammucari C (2011) Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 1: 4. doi: 10.1186/2044-5040-1-4
29. Iizuka K, Machida T, Hirafuji M (2014) Skeletal Muscle Is an Endocrine Organ. Journal of Pharmacological Sciences 125: 125-131.
30. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature genetics 27: 327-331.
31. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, et al. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890-893.
32. Li W, Pozzo-Miller L (2014) BDNF deregulation in Rett syndrome. Neuropharmacology C: 737-46. doi: 10.1016/j.neuropharm.2013.03.024
33. Abuhatzira L, Makedonski K, Kaufman Y, Razin A, Shemer R (2014) MeCP2 Deficiency in the Brain Decreases BDNF Levels by REST/CoREST-Mediated Repression and Increases TRKB Production. Epigenetics: official journal of the DNA Methylation Society 2: 214-222.
34. Chargé SBP, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiological reviews 84: 209-238.
35. Cronk JC, Derecki NC, Ji E, Xu Y, Lampano AE, Smirnov I, et al. (2015) Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli. Immunity 42: 679-91. doi: 10.1016/j.immuni.2015.03.013
36. Gow DJ, Sester DP, Hume DA (2010) CSF-1, IGF-1, and the control of postnatal growth and development. J Leukoc Biol 88: 475-81. doi: 10.1189/jlb.0310158
37. Lefaucheur JP, Gjata B, Lafont H, Sebille A (1996) Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-1 and transforming growth factor-beta 1. Journal of Neuroimmunology. 70: 37-44.
38. Lefaucheur JP, Sébille A (1995) Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. Journal of Neuroimmunology. 57: 85-91
39. Zordan P, Sciorati C, Campana L, Cottone L, Clementi E, Querini PR, et al. (2013) The nitric oxidedonor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy. European journal of pharmacology 715: 296-303. doi: 10.1016/j.ejphar.2013.05.007
40. Didier N, Hourdé C, Amthor H, Marazzi G, Sassoon D (2012) Loss of a single allele for Ku80 leads to progenitor dysfunction and accelerated aging in skeletal muscle. EMBO Mol Med 4: 910-23. doi: 10. 1002/emmm.201101075
41. Touvier T, De Palma C, Rigamonti E, Scagliola A, Incerti E, Mazelin L, et al. (2015) Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation. Cell Death Dis 6: e1663. doi: 10.1038/cddis.2014.595